Annual report pursuant to Section 13 and 15(d)

Stock-based Compensation - Additional Information (Details)

v3.24.0.1
Stock-based Compensation - Additional Information (Details)
 1 Months Ended 3 Months Ended 12 Months Ended
Jul. 31, 2021
purchase_period
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Oct. 01, 2023
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Jan. 01, 2023
USD ($)
$ / shares
shares
Jan. 02, 2022
USD ($)
$ / shares
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]            
Common stock options available for future grants (in shares)   36,945,880   36,945,880    
Stock-based compensation capitalized | $       $ 1,400,000 $ 1,800,000  
Unrecognized tax benefit | $       0 0 $ 0
Incremental stock based compensation expenses | $       $ 21,100,000 $ 0  
Weighted average grant date fair value (in dollars per share) | $ / shares       $ 0 $ 8.84 $ 4.43
Vested fair value of stock options | $       $ 15,100,000 $ 12,400,000 $ 6,600,000
Issuance of common stock subject to return (in shares)     1,304,954      
Equity Plan            
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]            
Lesser rate 4.00%          
Equity Awards            
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]            
Common stock options available for future grants (in shares)   14,698,737   14,698,737    
Accrued bonuses to be settled in equity awards | $   $ 1,000,000   $ 1,000,000    
Unrecognized stock-based compensation expenses related to nonvested equity awards | $   $ 118,300,000   $ 118,300,000    
Weighted average period of recognition for unrecognized stock-based compensation related to nonvested equity awards       3 years 9 months 18 days    
Equity Awards | Equity Plan | Common Stock            
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]            
Common stock options available for future grants (in shares) 16,850,000          
Stock options            
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]            
Common stock options available for future grants (in shares)   2,615,199   2,615,199    
Contractual term       10 years    
Cancellation period       3 months    
Repurchase right lapses period       90 days    
Shares remained subject to right of repurchase (in shares)       470,544 2,925,538  
Stock options | Minimum            
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]            
Vesting period       4 years    
Stock options | Maximum            
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]            
Vesting period       5 years    
RSUs            
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]            
Vested fair value of stock options | $       $ 35,300,000 $ 10,300,000  
Number of fully vested for incentive (in shares)   130,000        
Number of common stock shares upon vesting (in shares)   1   1    
Number of shares withheld (in shares)       303,805 48,739  
Total amounts paid for the employees' tax | $       $ 3,900,000 $ 600,000  
RSUs | Minimum            
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]            
Vesting period       4 years    
RSUs | Maximum            
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]            
Vesting period       5 years    
PRSUs            
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]            
Vesting period       2 years    
Vested fair value of stock options | $       $ 1,800,000    
ESPP            
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]            
Common stock options available for future grants (in shares) 5,625,000 8,207,204   8,207,204    
Lesser rate 1.00%          
Registrants common stock (in shares) 2,000,000          
Discount rate 15.00%          
Base compensation rate 15.00%          
ESPP offering period 18 months          
Number of purchase periods during offering period | purchase_period 3          
Term of purchase period 6 months          
Period of new offering period 6 months          
Fair market rate 85.00%          
Unrecognized stock-based compensation expenses related to nonvested equity awards | $   $ 2,000,000   $ 2,000,000    
Weighted average period of recognition for unrecognized stock-based compensation related to nonvested equity awards       1 year 4 months 24 days    
ESPP | Common Stock            
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]            
Weighted average grant date fair value (in dollars per share) | $ / shares       $ 12.56 $ 11.22  
Number of shares repurchased (in shares)       285,847 229,249  
Weighted-average purchase price per share (in dollars per share) | $ / shares   $ 8.22   $ 8.22 $ 8.29